Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Feb 17, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-	-	0.10
Net Debt / Equity Ratio	-1.08	-0.98	0.10
Quick Ratio	8.42	15.99	0.00
Current Ratio	8.77	17.30	2.23
Return on Equity (ROE)	-	-1013.73%	-
Return on Assets (ROA)	-	-74.36%	-
Return on Capital Employed (ROCE)	-144.00%	-92.40%	-296.10%
Buyback Yield / Dilution	-307.12%	-219.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q